Browse our collection of papers in
Pfizer Corporation
C/B/2388. Porter's 5 Forces analysis of Pfizer
- WORDS:
- 600
- DATE:
- 2010
- PRICE:
- 9.99 GBP
This paper presents an overview of Pfizer and Porter's 5 forces analysis of Pfizer, which is a framework for industry analysis and business strategy development and discusses the bargaining power of customers, bargaining power of suppliers, threat of new entrants and threat of substitute products and intensity of competitive rivalry affecting Pfizer.
KEYWORDS: Porter, 5 forces, five forces, Pfizer,
C/B/2387. PESTEL and Porter's 5 Forces analyses of Pfizer
- WORDS:
- 1500
- DATE:
- 2010
- PRICE:
- 19.99 GBP
This paper presents an overview of Pfizer, PESTEL analysis which stands for Political, Economic, Social, Technological, Environmental and Legal, analysing a framework of macro-environmental factors affecting Pfizer and Porter's 5 forces analysis of Pfizer which is a framework for industry analysis and business strategy development and discusses the bargaining power of customers, bargaining power of suppliers, threat of new entrants and threat of substitute products and intensity of competitive rivalry affecting Pfizer.
KEYWORDS: PEST, PESTEL, PESTLE, Porter, 5 forces, five forces, Pfizer,
C/B/2386. Value chain analysis of Pfizer
- WORDS:
- 950
- DATE:
- 2010
- PRICE:
- 9.99 GBP
This paper presents an overview of Pfizer, with Value Chain Analysis. Value Chain Analysis is a management tool used to identify key activities within the organisation which form its value chain: Inbound logistics, Operations, outbound logistics, marketing and sales, service, procurements, human resource management, technology development and firm infrastructure.
KEYWORDS: Value Chain, Inbound logistics, Operations, outbound logistics, marketing and sales, service, procurements, human resource management, technology development and firm infrastructure, Pfizer,
C/B/2385. SWOT and Value Chain Analyses of Pfizer
- WORDS:
- 1350
- DATE:
- 2010
- PRICE:
- 19.99 GBP
This paper presents an overview of Pfizer and SWOT analysis, which is a strategic planning method used to evaluate the strengths, weaknesses, opportunities and threats of Pfizer. Second part of the paper presents Value Chain Analysis of Pfizer.
KEYWORDS: SWOT, TOWS, Value Chain, Inbound logistics, Operations, outbound logistics, marketing and sales, service, procurements, human resource management, technology development and firm infrastructure, Pfizer,
C/B/2384. SWOT analysis of Pfizer
- WORDS:
- 600
- DATE:
- 2010
- PRICE:
- 9.99 GBP
This paper presents an overview of Pfizer, SWOT analysis, which is a strategic planning method used to evaluate the strengths, weaknesses, opportunities and threats of Pfizer.
C/B/2383. PESTEL and SWOT analyses of Pfizer
- WORDS:
- 1500
- DATE:
- 2010
- PRICE:
- 19.99 GBP
This paper presents an overview of Pfizer, SWOT analysis, which is a strategic planning method used to evaluate the strengths, weaknesses, opportunities and threats of Pfizer. It also includes a PESTEL analysis, which stands for Political, Economic, Social, Technological, Environmental and Legal, analysing a framework of macro-environmental factors affecting Pfizer.
KEYWORDS: PESTEL, PEST, SWOT, TOWS, Pfizer,
C/B/2382. PESTEL analysis of Pfizer
- WORDS:
- 1100
- DATE:
- 2010
- PRICE:
- 19.99 GBP
This paper presents an overview of Pfizer and PESTEL analysis, which stands for Political, Economic, Social, Technological, Environmental and Legal, analysing a framework of macro-environmental factors affecting Pfizer.
KEYWORDS: PEST, PESTEL, PESTLE, Pfizer,
C/B/2381. Strategic Analysis of Pfizer
- WORDS:
- 2050
- DATE:
- 2010
- PRICE:
- 29.99 GBP
This paper presents overview of Pfizer, PESTEL analysis, Porter’s 5 forces analysis and SWOT analysis of Pfizer.
KEYWORDS: PEST, PESTEL, PESTLE, SWOT, Porter, 5 forces, TOWS, Pfizer,
C/B/2380. PESTEL, Porter's 5 Forces, SWOT and Value Chain analyses of Pfizer
- WORDS:
- 2900
- DATE:
- 2010
- PRICE:
- 29.99 GBP
This paper presents overview of Pfizer, PESTEL analysis, Porter’s 5 forces analysis, SWOT and Value Chain analyses of Pfizer.
KEYWORDS: PEST, PESTEL, PESTLE, SWOT, Porter, 5 forces, TOWS, Value Chain, Pfizer,
C/B/2265. Strategic directions of pharmaceutical companies GSK, Pfizer and Novartis
- WORDS:
- 1250
- DATE:
- 2010
- PRICE:
- 19.99 GBP
The paper examines the strategic development of companies operating in the pharmaceutical industry, i.e. GlaxoSmithKline (GSK), Pfizer and Novartis. Key competences, capabilities and resources of GSK are discussed with references to the theory of strategy.
KEYWORDS: GlaxoSmithKline, GSK, Pfizer, Novartis, pharmaceutical industry, strategic directions,
C/B/2192. Company Strategies in Pharmaceutical Industry: Ansoff Analysis of Johnson & Johnson, Pfizer and Merck
- WORDS:
- 1500
- DATE:
- 2010
- PRICE:
- 19.99 GBP
The paper examines strategic directions in the development of three pharmaceutical companies, Johnson & Johnson (J&J), Pfizer and Merck describing the current situation within the industry and conducting comparative analysis of the companies’ products and markets using Ansoff matrix.
KEYWORDS: Pharmaceutical Industry, Ansoff Matrix, Johnson & Johnson, J&J, Pfizer, Merck,
C/B/2157. Strategic Direction of Pharmaceutical and Biotechnological Companies
- WORDS:
- 2200
- DATE:
- 2010
- PRICE:
- 29.99 GBP
The paper looks at the ongoing changes in the pharmaceutical (pharma) and biotechnological (biotech) industries addressing the challenges facing pharma and biotech companies, i.e. the safety and quality of their products, the pricing of medicines, and the need to engage in profitable commercial relations. Competitive strategies of Johnson & Johnson (J&J), Merck and Pfizer are described, key competences and capabilities of J&J are identified.
KEYWORDS: Pharmaceutical, biotechnological, medicines, Johnson & Johnson, J&J, Merck and Pfizer,
C/B/2156. Using Johnson & Johnson, Pfizer and Merck, identify the strategic direction, which each has chosen, from their websites and other sources. Using appropriate models and theory compare and contrast their strategies and judge which are most likely to succeed in the future. Identify the key competences, capabilities and resources held by 'one' of the companies chosen for the first part of this assignment. How well equipped is it to meet future challenges?
- WORDS:
- 2200
- DATE:
- 2010
- PRICE:
- 29.99 GBP
The paper looks at the ongoing changes in the pharmaceutical (pharma) and biotechnological (biotech) industries addressing the challenges facing pharma and biotech companies, i.e. the safety and quality of their products, the pricing of medicines, and the need to engage in profitable commercial relations. Competitive strategies of Johnson & Johnson (J&J), Merck and Pfizer are described, key competences and capabilities of J&J are identified.
KEYWORDS: Pharmaceutical, biotechnological, medicines, Johnson & Johnson, J&J, Merck and Pfizer,
C/B/451. Pfizer: Structure and strategy in the pharmaceutical industry (global perspective)
- WORDS:
- 1950
- DATE:
- 2006
- PRICE:
- 19.99 GBP
This paper examines trends in the macro-environment through PESTEL while the industry structure is analysed with the help of Porter's Five Forces. The analysis of Pfizer, the world's biggest pharmaceutical company, will be presented through a SWOT that will help us understand what is at stake.
KEYWORDS: Pfizer, PESTEL, SWOT, Porters Five Forces, drugs, pharmaceutical industry,
C/B/474. PESTEL analysis of Pfizer
- WORDS:
- 950
- DATE:
- 2006
- PRICE:
- 9.99 GBP
This paper presents overview of Pfizer and PESTEL Analysis which is analysing Political, Economic, Social, Technological, Environmental, and Legal factors affecting Pfizer.
C/B/475. SWOT analysis of Pfizer
- WORDS:
- 600
- DATE:
- 2006
- PRICE:
- 9.99 GBP
This paper presents overview of Pfizer and SWOT Analysis which is analysing strengths, weaknesses, opportunities and threats of Pfizer.
E/M/208. Pfizer's position in pharmaceutical industry
- WORDS:
- 1500
- DATE:
- 2006
- PRICE:
- 19.99 GBP
The paper reports on the pharmaceutical company Pfizer offering an overview of the industry environment and the development of pharmaceutical products. Analysis is conducted of Pfizer's micro-environment discussing their Marketing Mix features and suggesting recommendations about the company's business and financial strategies.
KEYWORDS: Pfizer, pharmaceutical, marketing mix,
P/B/732. Report on Pfizer, pharmaceutical manufacturer
- WORDS:
- 2000
- DATE:
- 2006
- PRICE:
- 29.99 GBP
The paper reports on Pfizer, a pharmaceutical company, describing their background, competences, competitive advantage, etc. The analysis of the company’s marketing environment is conducted using PEST and Porter’s Five Forces models. The internal environment is described using the audit of the physical, human, financial and other resources, operations, services, etc. The company’s strategic capability matrix is presented.
KEYWORDS: Pfizer, pharmaceutical, PEST, Porters Five Forces, resource audit,
P/B/80. Pfizer Corporation SWOT analysis
- WORDS:
- 1300
- DATE:
- 2003
- PRICE:
- 19.99 GBP
This paper presents company overview and SWOT analysis of Pfizer corporation, producer of Viagra
KEYWORDS: pfizer, corporation, swot,
Subject Catalogue
- Dissertations and Proposals
- Analysis of Companies
- Analysis of Industries
- Architecture, Design and Technology
- Computing and Mathematics
- E-Commerce and E-Business
- Economics
- Education
- Engineering
- Fashion and Culture
- Finance and Accounting
- General Business
- History
- Hospitality and Tourism
- Human Resource Management
- International Relations
- Law
- Literature, Language and Theatre Studies
- Management and Organisational Behaviour
- Marketing
- Media, Music and Art
- Operations Management
- Philosophy
- Politics
- Psychology
- Science, Medicine and Nursing
- Sociology
GET OUR GooGLE TOOLBAR BUTTON
BOOK MARK US
WHAT OTHERS HAVE SAID
Yes, thanks I received the paper. That was quick!Cheng
